Ozempic, Wegovy and Mounjaro, all GLP-1 anti-obesity medications, may offer health benefits beyond weight loss. Studies show the medications for Type 2 diabetes and weight loss can decrease the ...

“Ozempic can positively impact heart disease by reducing the risk of cardiovascular events, improving blood pressure and cholesterol levels, promoting weight loss, enhancing glycemic control ...

GLP-1 drugs currently being tested in China target complications associated with obesity such as heart disease, fatty liver ...

Australian doctors are in a quandary over powerful new evidence that shows high-dose Ozempic can effectively treat heart disease. Their problem is that this blockbuster drug is only approved in ...

In addition, Ozempic has not been FDA approved for its use in weight loss and should not be used for short-term weight loss. ... Obesity, like heart disease and high blood pressure, ...

The Food and Drug Administration approved Ozempic for treating patients with chronic kidney disease on Tuesday, marking the latest authorized use for Novo Nordisk’s popular drug known for ...

Skinny jab? Try skinny juice. A natural, plant-based drink enjoyed for centuries in South America may help you reach your weight loss goals the same way GLP-1 medications do. And it puts Ozempic ...

Currently, semaglutide (the medication in Ozempic) is approved only for type 2 diabetes and obesity treatment, although evidence shows that it can reduce the risk of heart disease, Stanford noted. ...

The cutting-edge weight-loss drug Ozempic/Wegovy can stop and even reverse fatty liver disease, a new clinical trial has found. Nearly twice as many people taking semaglutide stopped their fatty ...

The Food and Drug Administration approved Ozempic for treating patients with chronic kidney disease on Tuesday, marking the ...

Can popular weight-loss drugs like Ozempic stave off Alzheimer's disease? Ken Alltucker. USA TODAY. A popular new class of medications sheds pounds, treats diabetes and reduces heart disease risk.